{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:16:16Z","timestamp":1778868976947,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013414","name":"Conseil R\u00e9gional des Pays de la Loire","doi-asserted-by":"publisher","award":["ANR-10-IBHU-005"],"award-info":[{"award-number":["ANR-10-IBHU-005"]}],"id":[{"id":"10.13039\/501100013414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-17-CE17- 0007-01 TOLGENprogram"],"award-info":[{"award-number":["ANR-17-CE17- 0007-01 TOLGENprogram"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-09-BLAN-0265"],"award-info":[{"award-number":["ANR-09-BLAN-0265"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-INBS-04"],"award-info":[{"award-number":["ANR-10-INBS-04"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-17-CE17- 0007-01"],"award-info":[{"award-number":["ANR-17-CE17- 0007-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009406","name":"Centre Hospitalier Universitaire de Nantes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.omtm.2025.101409","type":"journal-article","created":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T10:19:27Z","timestamp":1737281967000},"page":"101409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immune-driven gene expression loss following intramuscular AAV delivery to non-human primates is only transient"],"prefix":"10.1016","volume":"33","author":[{"given":"Malo","family":"Journou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Devaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Jaulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Pichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanne","family":"Le Duff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Cuturi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micka\u00ebl","family":"Guilbaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9693-127X","authenticated-orcid":false,"given":"Oumeya","family":"Adjali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101409_bib1","first-page":"113","volume":"61","year":"2019","journal-title":"Med. Lett. Drugs Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.58347\/tml.2023.1686c","article-title":"Valoctocogene Roxaparvovec (Roctavian)\u00a0\u2013 A Gene Therapy for Severe Hemophilia A","volume":"65","year":"2023","journal-title":"Med. Lett. Drugs Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40265-023-01845-0","article-title":"Etranacogene Dezaparvovec: First Approval","volume":"83","author":"Heo","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.omtm.2025.101409_bib4","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s40265-023-01929-x","article-title":"Delandistrogene Moxeparvovec: First Approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.omtm.2025.101409_bib5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-virology-092818-015530","article-title":"Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?","volume":"6","author":"Keeler","year":"2019","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.omtm.2025.101409_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/mt.2011.237","article-title":"Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector","volume":"20","author":"Bowles","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1089\/hum.2013.169","article-title":"Immune Responses to Intramuscular Administration of Alipogene Tiparvovec (AAV1-LPLS447X) in a Phase II Clinical Trial of Lipoprotein Lipase Deficiency Gene Therapy","volume":"25","author":"Ferreira","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/mt.2014.200","article-title":"A phase 1\/2a follistatin gene therapy trial for becker muscular dystrophy","volume":"23","author":"Mendell","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib9","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood-2008-07-167510","article-title":"AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T\u00a0cells","volume":"114","author":"Mingozzi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101409_bib10","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ymthe.2017.03.029","article-title":"5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency","volume":"25","author":"Mueller","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/hum.2019.255","article-title":"Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.micro-dystrophin in the mdx Mouse Model of Duchenne Muscular Dystrophy","volume":"32","author":"Potter","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-0102(02)00195-5","article-title":"Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport","volume":"45","author":"Lu","year":"2003","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.omtm.2025.101409_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/jnc.13616","article-title":"Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer\u2019s disease-like pathologies in APP\/PS1 transgenic mice","volume":"138","author":"Wang","year":"2016","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.omtm.2025.101409_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood-2003-05-1446","article-title":"Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1","volume":"103","author":"Arruda","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101409_bib15","doi-asserted-by":"crossref","first-page":"11605","DOI":"10.1128\/JVI.76.22.11605-11611.2002","article-title":"Lack of an Immune Response against the Tetracycline-Dependent Transactivator Correlates with Long-Term Doxycycline-Regulated Transgene Expression in Nonhuman Primates after Intramuscular Injection of Recombinant Adeno-Associated Virus","volume":"76","author":"Favre","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2025.101409_bib16","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood-2003-11-3852","article-title":"Erythropoietin gene therapy leads to autoimmune anemia in macaques","volume":"103","author":"Gao","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101409_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/mthe.2001.0442","article-title":"Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation","volume":"4","author":"Herzog","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.28","article-title":"Generation and in\u00a0vivo evaluation of IL10-treated dendritic cells in a nonhuman primate model of AAV-based gene transfer","volume":"1","author":"Moreau","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101409_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/hum.2006.17.487","article-title":"Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation","volume":"17","author":"Ross","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/mt.2009.251","article-title":"Lack of Immunotoxicity After Regional Intravenous (RI) Delivery of rAAV to Nonhuman Primate Skeletal Muscle","volume":"18","author":"Toromanoff","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.omtm.2021.02.003","article-title":"AAV8 locoregional delivery induces long term expression of an immunogenic transgene in macaques despite persisting local inflammation. Molecular Therapy - Methods\u00a0& Clinical Development 0","volume":"20","author":"Gernoux","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101409_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1089\/hum.2010.194","article-title":"Evaluation of adeno-associated viral vectors for liver-directed gene transfer in dogs","volume":"22","author":"Bell","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/hum.2023.188","article-title":"Pre-existing immunity to a nucleic acid contaminant-derived antigen mediates transaminitis and resultant diminished transgene expression in a mouse model of hepatic rAAV-mediated gene transfer","volume":"35","author":"Brimble","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib24","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1089\/hum.2009.060","article-title":"Adeno-associated virus-mediated gene transfer to nonhuman primate liver can elicit destructive transgene-specific T\u00a0cell responses","volume":"20","author":"Gao","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1479-5876-12-25","article-title":"Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B","volume":"12","author":"Rogers","year":"2014","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.omtm.2025.101409_bib26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ymthe.2020.01.004","article-title":"Muscle-Directed Delivery of an AAV1 Vector Leads to Capsid-Specific T Cell Exhaustion in Nonhuman Primates and Humans","volume":"28","author":"Gernoux","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib27","doi-asserted-by":"crossref","first-page":"16363","DOI":"10.1073\/pnas.0904514106","article-title":"Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy","volume":"106","author":"Brantly","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101409_bib28","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1073\/pnas.1617726114","article-title":"Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for \u03b1-1-antitrypsin deficiency","volume":"114","author":"Calcedo","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101409_bib29","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1172\/JCI70314","article-title":"Human Treg responses allow sustained recombinant adeno-associated virus\u2013mediated transgene expression","volume":"123","author":"Mueller","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2025.101409_bib30","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1089\/hum.2018.234","article-title":"Five Years of Successful Inducible Transgene Expression Following Locoregional Adeno-Associated Virus Delivery in Nonhuman Primates with No Detectable Immunity","volume":"30","author":"Guilbaud","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib31","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/mt.2008.87","article-title":"Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle","volume":"16","author":"Toromanoff","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102538","article-title":"Transgene Regulation Using the Tetracycline-Inducible TetR-KRAB System after AAV-Mediated Gene Transfer in Rodents and Nonhuman Primates","volume":"9","author":"Le Guiner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101409_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-981-15-3266-5_2","article-title":"Molecular and Cellular Functions of CTLA-4","volume":"1248","author":"Van Coillie","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omtm.2025.101409_bib34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(85)91384-4","article-title":"INCREASED EXPRESSION OF HLA ABC CLASS I ANTIGENS BY MUSCLE FIBRES IN DUCHENNE MUSCULAR DYSTROPHY, INFLAMMATORY MYOPATHY, AND OTHER NEUROMUSCULAR DISORDERS","volume":"1","author":"Appleyard","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2025.101409_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0165-5728(02)00026-7","article-title":"Regulation of class I MHC expression in skeletal muscle: deleterious effect of aberrant expression on myogenesis","volume":"125","author":"Pavlath","year":"2002","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.omtm.2025.101409_bib36","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41587-023-01974-7","article-title":"Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration","volume":"42","author":"Greig","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2025.101409_bib37","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/mt.2012.277","article-title":"Differential Type I Interferon-dependent Transgene Silencing of Helper-dependent Adenoviral vs. Adeno-associated Viral Vectors In\u00a0Vivo","volume":"21","author":"Suzuki","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.02039-21","article-title":"Epigenetic Silencing of Recombinant Adeno-associated Virus Genomes by NP220 and the HUSH Complex","volume":"96","author":"Das","year":"2022","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2025.101409_bib39","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1016\/j.ymthe.2022.11.001","article-title":"Vector genome loss and epigenetic modifications mediate decline in transgene expression of AAV5 vectors produced in mammalian and insect cells","volume":"30","author":"Handyside","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib40","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/s41467-023-38106-3","article-title":"The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner","volume":"14","author":"Gonzalez-Sandoval","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2025.101409_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.omtm.2025.101409_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1089\/hum.2017.022","article-title":"Regulatory and Exhausted T Cell Responses to AAV Capsid","volume":"28","author":"Gernoux","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib43","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1128\/JVI.01253-07","article-title":"Vaccines based on novel adeno-associated virus vectors elicit aberrant CD8+ T-cell responses in mice","volume":"81","author":"Lin","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2025.101409_bib44","first-page":"3958","article-title":"Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T\u00a0cells in mice","volume":"117","author":"Lin","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2025.101409_bib45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/hum.2016.113","article-title":"Induction of T-Cell Infiltration and Programmed Death Ligand 2 Expression by Adeno-Associated Virus in Rhesus Macaque Skeletal Muscle and Modulation by Prednisone","volume":"28","author":"Cramer","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib46","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/blood-2008-01-131375","article-title":"Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy","volume":"113","author":"Velazquez","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101409_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/mt.2013.134","article-title":"AAV8 Induces Tolerance in Murine Muscle as a Result of Poor APC Transduction, T Cell Exhaustion, and Minimal MHCI Upregulation on Target Cells","volume":"22","author":"Mays","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101409_bib48","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ymthe.2003.12.015","article-title":"Optimal Design of a Single Recombinant Adeno-associated Virus Derived from Serotypes 1 and 2 to Achieve More Tightly Regulated Transgene Expression from Nonhuman Primate Muscle","volume":"9","author":"Chenuaud","year":"2004","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012500004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012500004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:55:35Z","timestamp":1778867735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S232905012500004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S232905012500004X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101409","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-driven gene expression loss following intramuscular AAV delivery to non-human primates is only transient","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101409"}}